Literature DB >> 12186172

Gene patents and the standard of care.

Richard Gold1, Timothy A Caulfield, Peter N Ray.   

Abstract

Keywords:  Genetics and Reproduction; Legal Approach

Mesh:

Year:  2002        PMID: 12186172      PMCID: PMC117472     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  8 in total

1.  Intellectual property. Patents, secrecy, and DNA.

Authors:  R M Cook-Deegan; S J McCormack
Journal:  Science       Date:  2001-07-13       Impact factor: 47.728

2.  Physicians' liability and drug formulary restrictions.

Authors:  Timothy Caulfield; Kerry Siminoski
Journal:  CMAJ       Date:  2002-02-19       Impact factor: 8.262

3.  Diagnostic testing fails the test.

Authors:  Jon F Merz; Antigone G Kriss; Debra G B Leonard; Mildred K Cho
Journal:  Nature       Date:  2002-02-07       Impact factor: 49.962

4.  Status, sale and patenting of human genetic material: an international survey.

Authors:  B M Knoppers
Journal:  Nat Genet       Date:  1999-05       Impact factor: 38.330

5.  The patenting of DNA.

Authors:  J J Doll
Journal:  Science       Date:  1998-05-01       Impact factor: 47.728

Review 6.  Can patents deter innovation? The anticommons in biomedical research.

Authors:  M A Heller; R S Eisenberg
Journal:  Science       Date:  1998-05-01       Impact factor: 47.728

7.  Disease gene patents: overcoming unethical constraints on clinical laboratory medicine.

Authors:  J F Merz
Journal:  Clin Chem       Date:  1999-03       Impact factor: 8.327

8.  American College of Medical Genetics position statement on gene patents and accessibility of gene testing.

Authors: 
Journal:  Genet Med       Date:  1999 Jul-Aug       Impact factor: 8.822

  8 in total
  6 in total

1.  The importance of being inventive. Critics claim that patents on genes may lead to very broad monopolies and inhibit further innovation. The European patent system provides efficient legal means to address these issues.

Authors:  Berthold Rutz; Siobhán Yeats
Journal:  EMBO Rep       Date:  2004-02       Impact factor: 8.807

Review 2.  Health care policy issues as a result of the genetic revolution: implications for public health.

Authors:  Rohit P Ojha; Raymond Thertulien
Journal:  Am J Public Health       Date:  2005-03       Impact factor: 9.308

3.  The helix in the labyrinth: do we need genetic health services and policy research?

Authors:  Fiona Alice Miller; Brenda Wilson; Jeremy Grimshaw; Renaldo Battista; Ingeborg Blancquaert; June C Carroll; François Rousseau; Barbara Slater
Journal:  Healthc Policy       Date:  2008-08

4.  What are gene patents and why are people worried about them?

Authors:  Jon F Merz; Mildred K Cho
Journal:  Community Genet       Date:  2005

5.  Commercial Opportunities and Ethical Pitfalls in Personalized Medicine: A Myriad of Reasons to Revisit the Myriad Genetics Saga.

Authors:  Derek So; Yann Joly
Journal:  Curr Pharmacogenomics Person Med       Date:  2013-06

6.  SARS genome patent: symptom or disease?

Authors:  E Richard Gold
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.